Corrigendum to ‘Mast cell activation test in chlorhexidine allergy: a proof of concept’ (Br J Anaesth 2020; 125: 970–5) (British Journal of Anaesthesia (2020) 125(6) (970–975), (S0007091220304827), (10.1016/j.bja.2020.06.024))

Jessy Elst, Marie Line M. van der Poorten, Margaretha A. Faber, Athina L. Van Gasse, Lene H. Garvey, Chris H. Bridts, Leander P. De Puysseleyr, Christel Mertens, Margo M. Hagendorens, Vito Sabato, Didier G. Ebo*

*Corresponding author for this work

Abstract

The authors regret that errors were present in the above article. The end concentrations of chlorhexidine should be 0.0025, 0.25, 25 and 2 500 ng mL−1. The corrected figure 2 is present below: [Figure presented] The corrected legend of figure 3 is also present below: Fig 3. Representative plots of mast cell activation tests with chlorhexidine. Cultured human mast cells were activated with chlorhexidine (2 500 ng ml−1) after passive sensitisation of the cells with serum of a patient with positive skin test and basophil activation test (ST+BAT+), or a patient with negative skin test and basophil activation test (ST–BAT–). The authors would like to apologise for any inconvenience caused.

Original languageEnglish
JournalBritish Journal of Anaesthesia
Volume126
Issue number3
Pages (from-to)748-749
Number of pages2
ISSN0007-0912
DOIs
Publication statusPublished - Mar 2021

Fingerprint

Dive into the research topics of 'Corrigendum to ‘Mast cell activation test in chlorhexidine allergy: a proof of concept’ (Br J Anaesth 2020; 125: 970–5) (British Journal of Anaesthesia (2020) 125(6) (970–975), (S0007091220304827), (10.1016/j.bja.2020.06.024))'. Together they form a unique fingerprint.

Cite this